Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The central hypothesis is to test Low Dose Fraction Radiotherapy (LDFRT), as a potentiator of
Docetaxel and Cisplatin efficacy in locally advanced nasopharyngeal cancer.